New and Upcoming Activities

This session explores the clinical and policy landscape of providing medications for opioid use disorder (MOUD) in jails, prisons, and reentry settings. Dr. Arthur Robin Williams and Dr. Peter Treitler review recent research on the effectiveness of MOUD in reducing overdose and improving post-release treatment engagement. The session highlights key differences among methadone, buprenorphine, and extended-release naltrexone, including regulatory and logistical considerations unique to correctional environments. Learners will examine policy updates, case-based examples, and implementation strategies that support evidence-based treatment access. The session also addresses interdisciplinary collaboration, diversion concerns, and continuity of care across incarceration and reentry.

This workshop introduces participants to the harm reduction mindset and how it bridges the treatment gap between full recovery and the process within its core principles and identify some pragmatic ways to integrate harm reduction into their respective settings.

This four-session online case-based learning collaborative series is designed for healthcare professionals treating individuals with opioid use disorder (OUD). Each 1.5-hour live, virtual session will feature an educational presentation on OUD and real-world case discussions led by addiction experts, providing practical insights and actionable strategies to improve patient care. Participants will explore best practices, discuss challenges, and collaborate on solutions in an engaging, interactive format.

Many cities, and especially cities with high real estate prices, have clearly defined zones in which public drug use and sales are implicitly tolerated while more stringent enforcement continues everywhere else. Given that addiction services (like methadone clinics or residential programs) are often mobilized to serve these zones and/or deliberately segregated to remain within them--what should our relationship to these zones be as addiction care providers? The podcast will explore the challenges, problems, and opportunities these zones can create for people who use drugs and the providers who care for them.

This training is available virtually. To register, please email: [email protected].

Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.

Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.